Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Buy
73
SBHMY Quote, Financials, Valuation and Earnings
Last price:
$9.48
Seasonality move
:
-1.59%
Day range:
$9.48 - $9.48
52-week range:
$6.69 - $10.30
Dividend yield:
2.17%
P/E ratio:
17.83x
P/S ratio:
2.16x
P/B ratio:
1.94x
Volume:
--
Avg. volume:
6
1-year change:
31.67%
Market cap:
$8.5B
Revenue:
$4B
EPS (TTM):
$0.53
Earnings Data
Next earnings date for SBHMY
Aug 13
2025
Most recent earnings per share
$0.15
Beat by $0.15
(Mar 23/2021)
Consensus Estimate
--
(Mar 23/2021)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SBHMY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2021 | Q4 | -- | -- | $0.15 | -- | -- |
| 11/30/2020 | Q3 | -- | -- | $0.09 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | $0.05 | -- | -- |
| 04/21/2020 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.08 | -- | -- |
| 11/26/2019 | Q3 | -- | -- | $0.12 | -- | -- |
| 09/27/2019 | Q2 | -- | -- | $0.09 | -- | -- |
| 05/21/2019 | Q1 | -- | -- | $0.13 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $1.07 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.13 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.10 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.09 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.08 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.12 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.06 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.07 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.04 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.05 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.07 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.05 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.05 | -- | -- |
Sino Biopharmaceutical Earnings Questions
-
How Much did Sino Biopharmaceutical Generate in Revenue Last Quarter?
Sino Biopharmaceutical reported -- worth of top line sales in its most recent quarter.
-
Did Sino Biopharmaceutical Beat Earnings Last Quarter?
Sino Biopharmaceutical announced earnings per share of $0.15 which represents a beat of analyst forecast a -- per share.
-
Is Sino Biopharmaceutical Profitable?
Sino Biopharmaceutical reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sino Biopharmaceutical EPS Next Year?
Sino Biopharmaceutical's earnings are forecast to grow from $0.53 per share to -- per share next year representing an increase of --.
-
When is Sino Biopharmaceutical's Earnings Date?
Sino Biopharmaceutical's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
57
TNXP alert for May 29
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Buy
70
AGFY alert for May 29
Agrify [AGFY] is up 18.95% over the past day.
Buy
87
SMR alert for May 29
NuScale Power [SMR] is down 0.37% over the past day.
